Cowen analyst J. Derrick Wood reiterated an Outperform rating and $160 price target on Splunk after attending its regional users conference, SplunkLive!, this week. In a research note to investors, Wood says he came away from the conference bullish on the demand environment, and says he sees additional catalysts on the horizon after hearing of strength in pricing and competitive win rates as well as growing traction with new products. Wood says he views current levels as an "attractive" buying opportunity given the recent underperformance in shares.

New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).